ConductScience.org, home

Paper37569749

Ivy Leaf Dry Extract EA 575® Has an Inhibitory Effect on the Signalling Cascade of Adenosine Receptor A2B.

Meurer F and 2 others. Int J Mol Sci, 2023. Cited by 4 papers, by iCite.

Cite this record

ConductScience Library. Ivy Leaf Dry Extract EA 575® Has an Inhibitory Effect on the Signalling Cascade of Adenosine Receptor A2B. Papers, record 37569749. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37569749

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Ivy Leaf Dry Extract EA 575® Has an Inhibitory Effect on the Signalling Cascade of Adenosine Receptor A2B.
PubMed
Journal
Int J Mol Sci
PubMed
Year
2023
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
4
iCite
Relative citation ratio, by iCite
0.86
iCite
Revised in PubMed
2026-03-10
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Meurer FFabio
2Häberlein HHanns
3Franken SSebastianhttps://orcid.org/0000-0003-4844-6389

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Receptor, Adenosine A2BMajor topic
Plant ExtractsMajor topic
Signal TransductionMajor topic
Plant LeavesMajor topic
Humans
HEK293 Cells
Cyclic AMP
beta-Arrestin 2
Interleukin-6

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
H-061.0037Engelhard Arzneimittel (Germany)PubMed

Source PubMed

Download CSV of grants

References91

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
111897989Plasma adenosine concentration increases during exercise: a possible contributing factor in exercise-induced bronchoconstriction in asthma.J Allergy Clin Immunol2002https://conductscience.org/library/papers/11897989PubMed
29478961Adenosine deaminase-deficient mice generated using a two-stage genetic engineering strategy exhibit a combined immunodeficiency.J Biol Chem1998https://conductscience.org/library/papers/9478961PubMed
32405250Involvement of a NF-kappa B-like transcription factor in the activation of the interleukin-6 gene by inflammatory lymphokines.Mol Cell Biol1990https://conductscience.org/library/papers/2405250PubMed
415472138Synergy between A2B adenosine receptors and hypoxia in activating human lung fibroblasts.Am J Respir Cell Mol Biol2005https://conductscience.org/library/papers/15472138PubMed
511591798Adenosine-dependent airway inflammation and hyperresponsiveness in partially adenosine deaminase-deficient mice.J Immunol2001https://conductscience.org/library/papers/11591798PubMed
625318478Deletion of ADORA2B from myeloid cells dampens lung fibrosis and pulmonary hypertension.FASEB J2015https://conductscience.org/library/papers/25318478PubMed
716280366Immunomodulatory impact of the A2A adenosine receptor on the profile of chemokines produced by neutrophils.FASEB J2006https://conductscience.org/library/papers/16280366PubMed
816236847Airway and systemic inflammation and decline in lung function in patients with COPD.Chest2005https://conductscience.org/library/papers/16236847PubMed
910899903Metabolic consequences of adenosine deaminase deficiency in mice are associated with defects in alveogenesis, pulmonary inflammation, and airway obstruction.J Exp Med2000https://conductscience.org/library/papers/10899903PubMed
102885756Binding of a nuclear protein to the cyclic-AMP response element of the somatostatin gene.Nature1987https://conductscience.org/library/papers/2885756PubMed
1129106905
Characterisation of endogenous A2A and A2B receptor-mediated cyclic AMP responses in HEK 293 cells using the GloSensor™ biosensor: Evidence for an allosteric mechanism of action for the A2B-selective antagonist PSB 603.
Biochem Pharmacol2018https://conductscience.org/library/papers/29106905PubMed
1224511476The Effect of Adenosine A2A and A2B Antagonists on Tracheal Responsiveness, Serum Levels of Cytokines and Lung Inflammation in Guinea Pig Model of Asthma.Adv Pharm Bull2014https://conductscience.org/library/papers/24511476PubMed
1331832428Efficacy of two dosing schemes of a liquid containing ivy leaves dry extract EA 575 versus placebo in the treatment of acute bronchitis in adults.ERJ Open Res2019https://conductscience.org/library/papers/31832428PubMed
1421496101Enhanced IL-6 transcriptional response to adenosine receptor ligands in horses with lower airway inflammation.Equine Vet J2012https://conductscience.org/library/papers/21496101PubMed
151374772Cytokines in symptomatic asthma airways.J Allergy Clin Immunol1992https://conductscience.org/library/papers/1374772PubMed
1619278262Alpha-hederin, but not hederacoside C and hederagenin from Hedera helix, affects the binding behavior, dynamics, and regulation of beta 2-adrenergic receptors.Biochemistry2009https://conductscience.org/library/papers/19278262PubMed
1723136556Role of IL-6 in asthma and other inflammatory pulmonary diseases.Int J Biol Sci2012https://conductscience.org/library/papers/23136556PubMed
181583242Expression of the potent inflammatory cytokines, granulocyte-macrophage-colony-stimulating factor and interleukin-6 and interleukin-8, in bronchial epithelial cells of patients with asthma.J Allergy Clin Immunol1992https://conductscience.org/library/papers/1583242PubMed
1920880874Sputum IL-6 concentrations in severe asthma and its relationship with FEV1.Thorax2011https://conductscience.org/library/papers/20880874PubMed
2031051404The A2A receptor agonist CGS 21680 has beneficial and adverse effects on disease development in a humanised mouse model of graft-versus-host disease.Int Immunopharmacol2019https://conductscience.org/library/papers/31051404PubMed

See all 91 referencesDownload CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.

PMIDTitleJournalYearIn PapersSource
42739377From Traditional Remedy to Evidence-Based Phytotherapeutic Agent: Hedera helix L. in Respiratory Medicine.Plants (Basel)2026https://conductscience.org/library/papers/42739377PubMed
42196994A Review of the Properties of Clinically Evaluated Plant-Derived Agents in the Treatment of Respiratory Infections.Nutrients2026https://conductscience.org/library/papers/42196994PubMed
40722746Efficacy of EA575 as an Antitussive and Mucoactive Agent in Preclinical In Vivo Models.Biomedicines2025https://conductscience.org/library/papers/40722746PubMed
40574085Ivy Leaf Dry Extract EA 575® Is a Potent Immunomodulator Acting on Dendritic Cells.Pharmaceutics2025https://conductscience.org/library/papers/40574085PubMed

Download CSV of cited by

Genes12

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/37569749

GET https://conductscience.org/api/papers/v1/37569749/references?page=2